Cao Xueyuan, Tsukamoto Tetsuya, Nozaki Koji, Tanaka Harunari, Shimizu Nobuyuki, Kaminishi Michio, Kumagai Toshiko, Tatematsu Masae
Division of Oncological Pathology, Aichi Cancer Center Research Institute, Chikusa-ku, Nagoya, Aichi 464-8681, Japan.
Jpn J Cancer Res. 2002 Dec;93(12):1293-8. doi: 10.1111/j.1349-7006.2002.tb01237.x.
Helicobacter pylori (H. pylori) is now well known to be associated with stomach cancer, with infection during childhood rather than as an adult considered to be more important for carcinogenesis. To evaluate the difference in susceptibility to stomach carcinogenesis in relation to age of acquisition of H. pylori infection, we designed an experiment involving inoculation of H. pylori ATCC43504 followed by N-methyl-N-nitrosourea (MNU) treatment at different ages. Four-week-old male Mongolian gerbils (MGs) were divided into twelve groups. H. pylori was inoculated at 4, 18 and 32 weeks of age, as representatives of early, middle and late infection, respectively. Two weeks later, the animals were treated with MNU. Groups without H. pylori and/or MNU were included as controls. The incidences of adenocarcinomas at 52 weeks after the inoculation in the early (H. pylori+MNU), middle (H. pylori+MNU), and late (H. pylori+MNU) group were 60% (12/20), 18.4% (2/11), and 10% (2/20), respectively. The corresponding figures were 14.8% (4/27), 0% (0/11), and 0% (0/21) in the MNU-alone groups. A higher titer of serum IgG for H. pylori and higher gastrin level were seen in the early-infected compared to the middle and the late groups (P<0.01). The results clearly demonstrated that early acquisition of H. pylori significantly increases gastric chemical carcinogenesis with MNU, as compared to the case with later infection, possibly because of differences in host gastric mucosal factors and immunologic responses.
幽门螺杆菌(H. pylori)现已被广泛认为与胃癌有关,儿童期感染而非成年期感染被认为对致癌作用更为重要。为了评估幽门螺杆菌感染年龄与胃癌发生易感性之间的差异,我们设计了一项实验,即接种幽门螺杆菌ATCC43504,然后在不同年龄进行N-甲基-N-亚硝基脲(MNU)处理。四周龄雄性蒙古沙鼠(MGs)被分为12组。分别在4周、18周和32周龄接种幽门螺杆菌,作为早期、中期和晚期感染的代表。两周后,对动物进行MNU处理。未接种幽门螺杆菌和/或未进行MNU处理的组作为对照。接种后52周时,早期(幽门螺杆菌+MNU)、中期(幽门螺杆菌+MNU)和晚期(幽门螺杆菌+MNU)组腺癌的发生率分别为60%(12/20)、18.4%(2/11)和10%(2/20)。仅接受MNU处理的组相应数字分别为14.8%(4/27)、0%(0/11)和0%(0/21)。与中期和晚期组相比,早期感染组的幽门螺杆菌血清IgG滴度更高,胃泌素水平更高(P<0.01)。结果清楚地表明,与后期感染相比,早期感染幽门螺杆菌显著增加了MNU诱导的胃化学致癌作用,这可能是由于宿主胃黏膜因素和免疫反应的差异所致。